USAIC has created an ecosystem committed to driving a global dialogue on BioPharma & Healthcare innovation, attracting a diverse mix of industry professionals.
Our 17th Biopharma Summit #USAIC23 (virtual event) starts tomorrow (May 3) at 8am EST with welcome remarks from emcee Dr. Andrew Plump.
Please join us for a program focused on delivering affordable innovation through global partnerships.
usaindiachamber.org/schedule…
#USAIC23 Annual BioPharma & Healthcare event starts with a presentation by Andy Plump, a scientist who needs no introduction for those who have attended the past USAIC events....
Looking forward to the discussion tomorrow morning w/ Rajiv Kaul, Chris Viehbacher, Stephen Knight, Sam Waksal, & Theresa Tse - we’ll talk about new approaches to financing R&D in the current environment, perspectives on M&A, single asset vs. diversified pipelines, and outlook for the coming year
This is a terrific conference and it’s free as a service to the BioPharma community usaindiachamber.org/schedule…linkedin.com/posts/karun-ris…#USAIC23@USAIC
ALT Don’t miss The CEO-to-CEO Conversation at #USAIC23: Johnson & Johnson's Chairman of the Board and CEO Joaquin Duato joins General Catalyst’s Kenneth C. Frazier (former Chairman & CEO of Merck) in a Fireside Chat about the future of BioPharma innovation, challenges facing the industry, diversity, equity and access.
Register now for USAIC’s 17th annual BioPharma & Healthcare Summit (May 3, virtual edition). Listen in to Duato, Frazier and an all-star lineup of BioPharma executives, investors and academic leaders in a virtual event chaired by Takeda's R&D President Andy Plump.
Free registration is available via our website as a service to the BioPharma community in these unprecedented times. Seats are limited. Please register today: https://usaindiachamber.org
The R&D Strategy & Trends panel at USAIC’s annual BioPharma Summit is always a highlight of the event. This year we celebrate our 17th anniversary on May 3 with an all-star panel moderated for the 15th time by Martin Mackay, Co-Founder of Rallybio, who is…lnkd.in/eqZqj6ni
CEO Fireside Chats headline USAIC’s 17th annual BioPharma & Healthcare Summit (May 3, virtual meeting). Listen to several C-level discussions between industry leaders, including a fireside chat between Pfizer Chairman & CEO Albert Bourla and Biogen Chairm…lnkd.in/e7ZBb6kJ
Thank you Karun for hosting such a lovely, reflective and meaningful USAIC event. We are so lucky to enjoy such a close knit, like-minded, fiercely competitive but impossibly collegial biopharma community on this Northeast corridor. Blown away by these luminary attendees.
Spent time w/friends in honor of new beginnings for Ken Frazier, Chris Viehbacher, @jaybradner, & @mmammen w/ laughter and collegiality anchored by a deep dedication to patients & science. Thanks Karun, Stelios, Andy & Elias for a terrific evening @USAIClinkedin.com/posts/karun-ris…
Spent time w/friends in honor of new beginnings for Ken Frazier, Chris Viehbacher, @jaybradner, & @mmammen w/ laughter and collegiality anchored by a deep dedication to patients & science. Thanks Karun, Stelios, Andy & Elias for a terrific evening @USAIClinkedin.com/posts/karun-ris…
Thank you to our Advisory Board, Speakers, Participants & Sponsors who made our 16th BioPharma Summit a success.
@USAIC's 17th annual BioPharma & Healthcare Summit (Virtual edition) is on May 3. Free Registration. Reserve your spot. Register link: usaindiachamber.org/speaker.…
A popular feature of #USAIC22: Industry KOLs asking in-depth Qs to panelists -> e.g., Biocon's @kiranshaw asks $JNJ Chairman Alex Gorsky about whether India can help with big pharma supply chain challenges. usaindiachamber.org/schedule…
Don't miss at 10:35am (ET) today, @benkoc is moderating a panel to discuss the Digital & Data Science at #USAIC22. It’s a virtual event so please join us at hubs.ly/Q01fsfHb0